bromodeoxyuridine has been researched along with dinoprostone in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (10.00) | 18.7374 |
| 1990's | 9 (45.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 2 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Mey, JG; Fazzi, GE; Janssen, GM; Schiffers, PM; Struijker-Boudier, HA | 1 |
| Boland, CR; Shimakura, S | 1 |
| De Mey, JG; Dijkstra, EH; Vrijdag, MJ | 1 |
| Abdel-Malek, ZA; Boissy, RE; Ferroni, EN; Nordlund, JJ; Swope, VB; Trinkle, LS | 1 |
| Kawai, K; Yamaguchi, N | 1 |
| Davie, MW; Holt, I; Marshall, MJ | 1 |
| Bennett, J; Delamere, F; Holland, E; Knox, A; Patel, S; Pavord, I | 1 |
| Dozi-Vassiliades, J; Kritsi, Z; Mioglou, E; Mourelatos, D | 1 |
| Jumblatt, MM | 1 |
| Ito, N; Kawabe, M; Sano, M; Shibata, MA; Shirai, T; Takesada, Y; Tamano, S | 1 |
| Konger, RL; Malaviya, R; Pentland, AP | 1 |
| Creminon, C; Hla, T; Huang, CK; Jang, BC; Liu, CH; Sanchez, T; Schaefers, HJ; Trifan, OC | 1 |
| Itoi, K; Kobayashi, T; Kumihashi, K; Kurosawa, S; Machida, T; Uchida, K | 1 |
| Hasan, M; Hillebrand, DJ; Hu, KQ; McCracken, JD; Mineyama, Y; Yu, CH | 1 |
| Kawamori, T; Sugimura, T; Uchiya, N; Wakabayashi, K | 1 |
| Boddy, SC; Jabbour, HN | 1 |
| D'Ambrosio, SM; Ding, H; Gibson-D'Ambrosio, R; Han, C; Steele, VE | 1 |
| Blandizzi, C; Breschi, MC; Colucci, R; Del Tacca, M; Tanini, M; Vassalle, C | 1 |
| Alvarez, S; Basile, L; Blanco, A; Di Pietro, P; Granata, G; Guccione, S; Muñoz-Fernández, MÁ; Santagati, A | 1 |
| Fernández-Martínez, AB; Lucio-Cazaña, J | 1 |
20 other study(ies) available for bromodeoxyuridine and dinoprostone
| Article | Year |
|---|---|
Endothelial modulation of DNA synthesis in isolated arteries of the rat.
Topics: Aging; Animals; Bromodeoxyuridine; Carotid Arteries; Dinoprostone; DNA; Endothelium, Vascular; Iloprost; Indomethacin; Male; Methylene Blue; Organ Culture Techniques; Rats; Rats, Inbred WKY; Renal Artery; Transforming Growth Factor beta; Tunica Media | 1992 |
Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth.
Topics: Arachidonic Acid; Bromodeoxyuridine; Cell Division; Chromatography, High Pressure Liquid; Dinoprostone; DNA Replication; Dose-Response Relationship, Drug; Eicosanoids; Humans; Hydrocortisone; Masoprocol; Mitotic Index; Prostaglandin D2; SRS-A; Stomach Neoplasms; Thymidine; Tritium; Tumor Cells, Cultured | 1992 |
Endothelium reduces DNA synthesis in isolated arteries.
Topics: Acetylcholine; Animals; Atrial Natriuretic Factor; Bromodeoxyuridine; Colforsin; Culture Techniques; Cyclic AMP; Cyclic GMP; Dinoprostone; DNA; Endothelium, Vascular; Iloprost; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroprusside; Potassium; Rats; Rats, Inbred WKY; Renal Artery; Sympathectomy | 1991 |
Alteration of the Cloudman melanoma cell cycle by prostaglandins E1 and E2 determined by using a 5-bromo-2'-deoxyuridine method of DNA analysis.
Topics: Alprostadil; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; Cell Line; Dinoprost; Dinoprostone; DNA; Melanoma; Mice; Microscopy, Electron; Monophenol Monooxygenase; Prostaglandins E; Prostaglandins F | 1988 |
Factors affecting the CEA secretion of human adenocarcinoma cell lines into the spent medium.
Topics: Adenocarcinoma; Bromodeoxyuridine; Bucladesine; Carcinoembryonic Antigen; Cell Line; Culture Media; Cyclic AMP; Dimethyl Sulfoxide; Dinoprostone; Humans; Interferon Type I; Prostaglandins E; Theophylline | 1983 |
The number of tartrate-resistant acid phosphatase-positive osteoclasts on neonatal mouse parietal bones is decreased when prostaglandin synthesis is inhibited and increased in response to prostaglandin E2, parathyroid hormone, and 1,25 dihydroxyvitamin D3
Topics: Acid Phosphatase; Animals; Animals, Newborn; Bromodeoxyuridine; Calcitriol; Cell Differentiation; Cell Nucleus; Culture Media; Dinoprostone; Down-Regulation; Mice; Mice, Inbred CBA; Osteoclasts; Parathyroid Hormone; Parietal Bone; Prostaglandins; Staining and Labeling | 1995 |
Production of PGE2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo-oxygenase inhibitors.
Topics: Animals; Aspirin; Bromodeoxyuridine; Cattle; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Indomethacin; Muscle, Smooth; Trachea | 1994 |
Enhancement of antineoplastic effect and attenuation of sister chromatid exchanges by prostaglandin E2 in Ehrlich ascites tumour cells treated with cyclophosphamide in vivo.
Topics: Animals; Bromodeoxyuridine; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Dinoprostone; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Sister Chromatid Exchange; Tumor Cells, Cultured | 1993 |
PGE2 synthesis and response pathways in cultured corneal endothelial cells: the effects of in vitro aging.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cells, Cultured; Cellular Senescence; Cyclic AMP; Dinoprostone; Endothelium, Corneal; Flow Cytometry; Rabbits; Radioimmunoassay; Receptors, Prostaglandin E | 1997 |
Decrease of prostaglandin E2 and 5-bromo-2'-deoxyuridine labeling but not prostate tumor development by indomethacin treatment of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.
Topics: Aminobiphenyl Compounds; Animals; Body Weight; Bromodeoxyuridine; Dinoprostone; DNA; Indomethacin; Male; Organ Size; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Seminal Vesicles; Testosterone | 1997 |
Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes.
Topics: Abortifacient Agents, Nonsteroidal; Adenylyl Cyclases; Bromodeoxyuridine; Bucladesine; Cell Division; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression; Humans; Indomethacin; Keratinocytes; Misoprostol; Oxytocics; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; RNA; Transcription, Genetic | 1998 |
Serum withdrawal-induced post-transcriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase.
Topics: Apoptosis; Blotting, Northern; Blotting, Western; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Cell Nucleus; Culture Media, Serum-Free; Cyclooxygenase 2; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Genes, Dominant; Humans; Imidazoles; Isoenzymes; Membrane Proteins; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Nucleic Acid Synthesis Inhibitors; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines; RNA Processing, Post-Transcriptional; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Tumor Cells, Cultured | 2000 |
Stimulatory effects of prostaglandin E2 on neurogenesis in the dentate gyrus of the adult rat.
Topics: Animals; Antigens, Nuclear; Bromodeoxyuridine; Cell Differentiation; Cell Division; Dentate Gyrus; Dinoprostone; Male; Neural Cell Adhesion Molecules; Neurons; Rats; Rats, Inbred F344 | 2002 |
Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Immunohistochemistry; Isoenzymes; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Sulfonamides; Time Factors | 2003 |
Enhancement of colon carcinogenesis by prostaglandin E2 administration.
Topics: Adenocarcinoma; Animals; Apoptosis; Azoxymethane; Bromodeoxyuridine; Carcinogens; Colon; Colonic Neoplasms; Dinoprostone; Disease Progression; DNA Primers; Incidence; Injections, Intraperitoneal; Intestinal Mucosa; Male; Rats; Rats, Inbred F344; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Prostaglandin E2 induces proliferation of glandular epithelial cells of the human endometrium via extracellular regulated kinase 1/2-mediated pathway.
Topics: Adult; Antimetabolites; Blotting, Western; Bromodeoxyuridine; Cell Division; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Endometrium; Epithelial Cells; Female; Humans; Immunohistochemistry; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Phosphorylation; Receptors, Prostaglandin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2003 |
Piroxicam selectively inhibits the growth of premalignant and malignant human oral cell lines by limiting their progression through the S phase and reducing the levels of cyclins and AP-1.
Topics: Base Sequence; Bromodeoxyuridine; Cell Division; Cell Line; Cell Survival; Cyclooxygenase Inhibitors; Dinoprostone; DNA Primers; Humans; Mouth Mucosa; Mouth Neoplasms; Piroxicam; Polymerase Chain Reaction; Precancerous Conditions; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2003 |
Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production.
Topics: Antimetabolites; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; DNA; Enzyme Induction; Gastrins; HT29 Cells; Humans; Isoenzymes; Luciferases; Membrane Proteins; Phosphatidylinositol 3-Kinases; Promoter Regions, Genetic; Prostaglandin-Endoperoxide Synthases; Receptor, Cholecystokinin B; Receptors, Prostaglandin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction | 2005 |
Sulfonilamidothiopyrimidone and thiopyrimidone derivatives as selective COX-2 inhibitors: synthesis, biological evaluation, and docking studies.
Topics: Blotting, Western; Bromodeoxyuridine; Catalytic Domain; Cell Death; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Interleukin-2; Leukocytes, Mononuclear; Molecular Docking Simulation; Pyrimidinones; Structure-Activity Relationship; Sulfonamides; Thermodynamics; Thiadiazoles | 2012 |
Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.
Topics: Analysis of Variance; Blotting, Western; Bromodeoxyuridine; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dinoprostone; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Microscopy, Fluorescence; Neovascularization, Pathologic; Phenotype; Prostatic Neoplasms; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Tetrazolium Salts; Thiazoles | 2015 |